-
10006735-5The biological effects of PGD2 are transduced by at least two 7-transmembrane G-protein coupled receptors, designated DP1 and CRTH2/DP2. BAY-u3405 (Ramatroban) is an approved human medication for the treatment of allergic rhinitis that has
-
10006735-50The biological effects of PGD2 are transduced by at least two 7-transmembrane G-protein coupled receptors, designated DP1 and CRTH2/DP2. BAY-u3405 (Ramatroban) is an approved human medication for the treatment of allergic rhinitis that has
-
10006482-10An inhibitor of human ACAT-1 and ACAT-2 with an IC50 values of 95 and 81 µM, respectively inhibits cooper-mediated oxidation of LDL by 91% at concentration of 2 µM.
-
10006482-100An inhibitor of human ACAT-1 and ACAT-2 with an IC50 values of 95 and 81 µM, respectively inhibits cooper-mediated oxidation of LDL by 91% at concentration of 2 µM.
-
10006482-5An inhibitor of human ACAT-1 and ACAT-2 with an IC50 values of 95 and 81 µM, respectively inhibits cooper-mediated oxidation of LDL by 91% at concentration of 2 µM.
-
10006482-50An inhibitor of human ACAT-1 and ACAT-2 with an IC50 values of 95 and 81 µM, respectively inhibits cooper-mediated oxidation of LDL by 91% at concentration of 2 µM.
-
10006452-10An inhibitor of human ACAT-1 and ACAT-2 with an IC50 value of approximately 60 µM for both enzymes also inhibits copper-mediated oxidation of LDL by about 20% at a concentration of 3 µM.
-
10006452-5An inhibitor of human ACAT-1 and ACAT-2 with an IC50 value of approximately 60 µM for both enzymes also inhibits copper-mediated oxidation of LDL by about 20% at a concentration of 3 µM.
-
10006452-50An inhibitor of human ACAT-1 and ACAT-2 with an IC50 value of approximately 60 µM for both enzymes also inhibits copper-mediated oxidation of LDL by about 20% at a concentration of 3 µM.
-
10006452-500An inhibitor of human ACAT-1 and ACAT-2 with an IC50 value of approximately 60 µM for both enzymes also inhibits copper-mediated oxidation of LDL by about 20% at a concentration of 3 µM.
-
10006480-10The early stage of atherosclerosis is characterized by the aggregation of foam cells, so called a fatty streak, in the inner arterial wall. CAY10487 inhibits formation of fatty streak lesions of the thoracic aorta in high cholesterol-fed rabbits
-
10006480-5The early stage of atherosclerosis is characterized by the aggregation of foam cells, so called a fatty streak, in the inner arterial wall. CAY10487 inhibits formation of fatty streak lesions of the thoracic aorta in high cholesterol-fed rabbits